检验医学 ›› 2025, Vol. 40 ›› Issue (9): 862-866.DOI: 10.3969/j.issn.1673-8640.2025.09.006

• 论著 • 上一篇    下一篇

肺结核患者血清miR-125b、miR-423表达与疾病活动性、预后的关系

傅爱   

  1. 南华大学附属长沙中心医院结核科,湖南 长沙 410004
  • 收稿日期:2024-04-27 修回日期:2025-02-19 出版日期:2025-09-30 发布日期:2025-09-30
  • 作者简介:傅 爱,女,1982年生,硕士,副主任医师,主要从事结核病的诊治工作。

Relationship between serum miR-125b and miR-423 expressions in patients with pulmonary tuberculosis and the disease activity and prognosis

FU Ai   

  1. Department of Tuberculosis,Changsha Central Hospital Affiliated to South China University,Changsha 410004,Hunan,China
  • Received:2024-04-27 Revised:2025-02-19 Online:2025-09-30 Published:2025-09-30

摘要:

目的 探讨血清miR-125b、miR-423表达与肺结核疾病活动性和患者预后的关系。方法 选取2020年1月—2021年6月南华大学附属长沙中心医院活动性肺结核(APTB)患者102例(APTB组)、潜伏结核感染(LTBI)患者112例(LTBI组)和健康体检者120名(正常对照组)。检测所有研究对象血清miR-125b、miR-423相对表达量和血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平。根据APTB患者治疗6个月后的疗效分为临床控制组(86例)和未控制组(16例)。采用Pearson相关分析评估血清miR-125b、miR-423表达与TNF-α、IL-6水平的相关性。采用受试者工作特征(ROC)曲线评价各项指标判断APTB患者临床未控制的效能。结果 正常对照组、LTBI组、APTB组血清miR-125b、miR-423相对表达量和血清TNF-α、IL-6水平依次升高(P<0.001)。未控制组血清miR-125b、miR-423相对表达量和血清TNF-α、IL-6水平均高于临床控制组(P<0.001)。miR-423、miR-125b单项检测判断APTB患者临床未控制的曲线下面积(AUC)分别为0.830、0.852,miR-423+miR-125b、miR-423+miR-125b+TNF-α+IL-6联合检测判断APTB患者临床未控制的AUC分别为0.910、0.942。APTB患者血清miR-125b、miR-423表达与IL-6、TNF-α水平均呈正相关(P<0.001)。结论 APTB患者血清miR-125b、miR-423表达显著升高,在APTB疾病活动性判断和疗效评估中有较高的临床价值。

关键词: 微小RNA-125b, 微小RNA -423, 肺结核, 潜伏结核感染, 活动期, 预后

Abstract:

Objective To investigate the relationship between the expressions of serum miR-125b and miR-423 and the activity of pulmonary tuberculosis and the prognosis of patients. Methods A total of 102 patients with active pulmonary tuberculosis(APTB)(APTB group),112 patients with latent tuberculosis infection(LTBI)(LTBI group) and 120 healthy subjects(healthy control group)were enrolled from January 2020 to June 2021 in Changsha Central Hospital Affiliated to South China University. The relative expression levels of serum miR-125b and miR-423 and the levels of serum tumor necrosis factor-alpha(TNF-α)and interleukin-6(IL-6)were determined. According to the therapeutic effect of APTB patients after 6 months of treatment,they were classified into clinical control group(86 cases)and clinical non-control group(16 cases). Pearson correlation analysis was used to evaluate the correlation between the expressions of serum miR-125b and miR-423 and the levels of TNF-α and IL-6. Receiver operating characteristic(ROC)curve was used to evaluate the efficacy of each index in judging the clinical non-control of APTB patients. Results The relative expression levels of serum miR-125b and miR-423 and the levels of serum TNF-α and IL-6 in healthy control group,LTBI group and APTB group were increased successively(P<0.001). The relative expression levels of serum miR-125b and miR-423 and the levels of serum TNF-α and IL-6 in clinical non-control group were higher than those in clinical control group(P<0.001). The areas under curves(AUC)of miR-423 and miR-125b single determinations for judging the clinical non-control of APTB patients were 0.830 and 0.852,respectively. The AUC of miR-423+miR-125b and miR-423+miR-125b+TNF-α+IL-6 combined determinations for judging the clinical non-control of APTB patients were 0.910 and 0.942,respectively. The expressions of miR-125b and miR-423 in the serum of APTB patients were positively correlated with the levels of IL-6 and TNF-α(P<0.001). Conclusions The expressions of miR-125b and miR-423 in the serum of APTB patients are increased,with high clinical value in the judgment of disease activity and therapeutic effect evaluation of APTB.

Key words: MicroRNA-125b, MicroRNA-423, Pulmonary tuberculosis, Latent tuberculosis infection, Active stage, Prognosis

中图分类号: